TENSOR ACCESSION USING HUMAN PLACENTAL PERFUSAT AND AUXILIARY NATURAL KILLER CELLS ALLOCATED FROM HUMAN PLACENTA

摘要

1. A composition comprising human placental perfusate cells for use in a method of inhibiting tumor cell proliferation in vivo or in vitro. ! 2. The composition according to claim 1, where the tumor cells are blood cancer cells. ! 3. The composition according to claim 1, where the tumor cells are solid tumor cells. ! 4. The composition according to claim 1, where the tumor cells are primary carcinoma cells from ductal epithelium, leukemia cells, acute T-cell leukemia cells, chronic myeloid lymphoma (CML) cells, acute myelogenous leukemia cells, chronic myelogenous leukemia (CML) cells, pulmonary carcinoma cells, colon adenocarcinoma cells, histiocytic lymphoma cells, colorectal carcinoma cells, colorectal adenocarcinoma cells or retinoblastoma cells. ! 5. The composition according to claim 1, where the specified suppression occurs in vitro. ! 6. The composition according to claim 1, where the specified suppression occurs in vivo. ! 7. The composition according to claim 6, where the specified suppression occurs in a person. ! 8. The composition according to claim 1, where the specified set of cells of placental perfusate is a collection of nucleated cells from placental perfusate. ! 9. The composition of claim 1, wherein said placental perfusate cells are processed to remove at least one type of cell. ! 10. The composition according to claim 1, where these cells of the placental perfusate are processed in order to enrich with at least one type of cell. ! 11. The composition of claim 1, wherein said placental perfusate cells contain at least about 50% of placenta CD56 + cells. ! 12. The composition containing the selected CD